Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIa study of a 10-valent pneumococcal conjugate vaccine in infants
2005-003299-40Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2005
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of 10-valent pneumococcal conjugate vaccine in pneumococcal disease (2 arms), sponsored by GSK. Primary endpoint: Serotype-specific antibody response after dose 3. Started Aug 2005; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2005-003299-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003299-40.